On September 28, scientists from Sanford Burnham Prebys demonstrated that briefly altering heart cell metabolism can reactivate dormant self-repair mechanisms in adult mammalian hearts. By using a metabolite called malonate to drive succinate dehydrogenase inhibition, researchers successfully shifted adult mouse cells back into a neonatal-like energy state, reducing scar tissue and spurring the growth of new blood vessels following a cardiac event.
Coordinating a Multicellular Response
The therapeutic effect relies on the coordinated reaction of different cardiac components. When investigators evaluated the metabolic shift in isolated environments, they discovered that simply prompting heart muscle cells to multiply was inadequate for overall functional recovery. Instead, the temporary enzymatic block also needed to affect cardiac fibroblasts, significantly suppressing their tendency to form damaging fibrous scars after an injury.
Epigenetic Adjustments Limit Scarring
This dual action is driven by epigenetic modifications, where the physical packaging of DNA inside the cells shifts to either expose or hide specific genetic instructions. In the muscle cells, DNA regions controlling regeneration loosen and activate. Simultaneously, the structural connective cells tighten their DNA spools around the genes responsible for fibrosis, effectively turning off the scarring process.
Unlike permanent genetic modifications, the transient nature of this intervention is crucial. It allows the injured tissue to briefly enter a regenerative phase before reverting to the mature energy production necessary for regular pumping. The research team aims to translate this strategy into clinical treatments for hundreds of thousands of patients who survive severe cardiac emergencies every year.